Division of Breast Surgery, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
J Surg Oncol. 2022 Jun;125(8):1326-1331. doi: 10.1002/jso.26847. Epub 2022 Mar 12.
Germline CDH1 defects are related with the development of multiple cancers due its pleiotropic nature. These several conditions are associated with various risks of penetrance and with different clinical management strategies. In this clinical review, we described the penetrance risks of gastric, breast, prostate, and colorectal cancers, in CDH1 carriers, within as well as outside the familial setting, and the best approaches to manage each risk, using either prophylactic surgery or surveillance.
胚系 CDH1 缺陷因其多效性而与多种癌症的发生有关。这些疾病与不同的外显率风险和不同的临床管理策略相关。在本次临床综述中,我们描述了 CDH1 携带者在家族性和非家族性环境中发生胃癌、乳腺癌、前列腺癌和结直肠癌的外显率风险,以及使用预防性手术或监测来管理每种风险的最佳方法。